Arie Belldegrun Insider Trading $CGRB Cougar Biotechnology, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arie Belldegrun.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arie Belldegrun. Arie Belldegrun is Director in Talon Therapeutics, Inc. ($EMLR) and Director in Arno Therapeutics, Inc ($ARNI) and Director in Cougar Biotechnology, Inc. ($CGRB) and Chairman, President and CEO in Kite Pharma, Inc. ($KITE) and Director in UroGen Pharma Ltd. ($URGN) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO) and Director in Kronos Bio, Inc. ($KRON).
Arie Belldegrun in Cougar Biotechnology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Arie Belldegrun: Director
Holdings: 64,664 shares
Latest Transaction: Mar 03 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arie Belldegrun in Cougar Biotechnology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLO, ARNI, CGRB, KITE, KRON, EMLR, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2008 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 27.00 | 4,700 | 126,900 | 64,664 | 60 K to 64.7 K (+7.84 %) |
| Mar 03 2008 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 26.99 | 300 | 8,097 | 59,964 | 59.7 K to 60 K (+0.50 %) |
| Dec 20 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 30.50 | 15,000 | 457,500 | 59,664 | 44.7 K to 59.7 K (+33.58 %) |
| Jun 19 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 23.90 | 3,700 | 88,430 | 44,664 | 41 K to 44.7 K (+9.03 %) |
| Jun 13 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Option Exercise | A | 24.50 | 10,000 | 245,000 | 10,000 | |
| May 10 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 21.10 | 7,100 | 149,810 | 40,964 | 33.9 K to 41 K (+20.97 %) |
| Mar 09 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 18.55 | 1,000 | 18,550 | 33,864 | 32.9 K to 33.9 K (+3.04 %) |
| Mar 09 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 18.85 | 500 | 9,425 | 32,864 | 32.4 K to 32.9 K (+1.54 %) |
| Mar 09 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 18.40 | 5,500 | 101,200 | 32,364 | 26.9 K to 32.4 K (+20.47 %) |
| Mar 09 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 18.30 | 4,000 | 73,200 | 26,864 | 22.9 K to 26.9 K (+17.49 %) |
| Mar 09 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Buy | P | 18.15 | 4,000 | 72,600 | 22,864 | 18.9 K to 22.9 K (+21.20 %) |
| Jan 10 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Option Exercise | A | 2.60 | 38,411 | 99,869 | 38,411 | |
| Jan 10 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Option Exercise | D | 0.39 | 38,411 | 14,999 | 38,411 | |
| Jan 10 2007 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Grant | A | 0.00 | 18,864 | 0 | 18,864 | 0 to 18.9 K |
| Sep 11 2006 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Option Exercise | A | 4.50 | 200,000 | 900,000 | 200,000 | |
| Sep 11 2006 | CGRB | Cougar Biotechnolo ... | Belldegrun Arie | Director | Option Exercise | A | 4.50 | 30,000 | 135,000 | 30,000 |
Page: 1